Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy

This study has been completed.
Sponsor:
Collaborator:
Adaptimmune
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00991224
First received: October 6, 2009
Last updated: February 20, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)